These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 39151979)
1. The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study. Bansi-Matharu L; Revill P; Taramusi I; Steen R; Chabata ST; Busza J; Mangenah C; Musemburi S; Machingura F; Desmond N; Matambanadzo P; Shahmanesh M; Yekeye R; Mugurungi O; Cowan FM; Hargreaves JR; Phillips AN Lancet Glob Health; 2024 Sep; 12(9):e1436-e1445. PubMed ID: 39151979 [TBL] [Abstract][Full Text] [Related]
2. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H; PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256 [TBL] [Abstract][Full Text] [Related]
3. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis. Stone J; Bothma R; Gomez GB; Eakle R; Mukandavire C; Subedar H; Fraser H; Boily MC; Schwartz S; Coetzee J; Otwombe K; Milovanovic M; Baral S; Johnson LF; Venter WDF; Rees H; Vickerman P J Int AIDS Soc; 2023 Feb; 26(2):e26063. PubMed ID: 36807874 [TBL] [Abstract][Full Text] [Related]
4. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study. Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Phillips AN; Bershteyn A; Revill P; Bansi-Matharu L; Kripke K; Boily MC; Martin-Hughes R; Johnson LF; Mukandavire Z; Jamieson L; Meyer-Rath G; Hallett TB; Ten Brink D; Kelly SL; Nichols BE; Bendavid E; Mudimu E; Taramusi I; Smith J; Dalal S; Baggaley R; Crowley S; Terris-Prestholt F; Godfrey-Faussett P; Mukui I; Jahn A; Case KK; Havlir D; Petersen M; Kamya M; Koss CA; Balzer LB; Apollo T; Chidarikire T; Mellors JW; Parikh UM; Godfrey C; Cambiano V; Lancet HIV; 2022 May; 9(5):e353-e362. PubMed ID: 35489378 [TBL] [Abstract][Full Text] [Related]
6. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Smith J; Bansi-Matharu L; Cambiano V; Dimitrov D; Bershteyn A; van de Vijver D; Kripke K; Revill P; Boily MC; Meyer-Rath G; Taramusi I; Lundgren JD; van Oosterhout JJ; Kuritzkes D; Schaefer R; Siedner MJ; Schapiro J; Delany-Moretlwe S; Landovitz RJ; Flexner C; Jordan M; Venter F; Radebe M; Ripin D; Jenkins S; Resar D; Amole C; Shahmanesh M; Gupta RK; Raizes E; Johnson C; Inzaule S; Shafer R; Warren M; Stansfield S; Paredes R; Phillips AN; Lancet HIV; 2023 Apr; 10(4):e254-e265. PubMed ID: 36642087 [TBL] [Abstract][Full Text] [Related]
7. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study. Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057 [TBL] [Abstract][Full Text] [Related]
8. Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis. Phillips AN; Cambiano V; Nakagawa F; Bansi-Matharu L; Wilson D; Jani I; Apollo T; Sculpher M; Hallett T; Kerr C; van Oosterhout JJ; Eaton JW; Estill J; Williams B; Doi N; Cowan F; Keiser O; Ford D; Hatzold K; Barnabas R; Ayles H; Meyer-Rath G; Nelson L; Johnson C; Baggaley R; Fakoya A; Jahn A; Revill P J Int AIDS Soc; 2019 Jul; 22(7):e25325. PubMed ID: 31287620 [TBL] [Abstract][Full Text] [Related]
9. Community mobilisation and empowerment interventions as part of HIV prevention for female sex workers in Southern India: a cost-effectiveness analysis. Vassall A; Chandrashekar S; Pickles M; Beattie TS; Shetty G; Bhattacharjee P; Boily MC; Vickerman P; Bradley J; Alary M; Moses S; ; Watts C PLoS One; 2014; 9(10):e110562. PubMed ID: 25333501 [TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa. Quaife M; Terris-Prestholt F; Eakle R; Cabrera Escobar MA; Kilbourne-Brook M; Mvundura M; Meyer-Rath G; Delany-Moretlwe S; Vickerman P J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537654 [TBL] [Abstract][Full Text] [Related]
11. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis. Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485 [TBL] [Abstract][Full Text] [Related]
12. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries. Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512 [TBL] [Abstract][Full Text] [Related]
13. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness. Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936 [TBL] [Abstract][Full Text] [Related]
14. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers. Mukandavire Z; Mitchell KM; Vickerman P Epidemics; 2016 Mar; 14():62-70. PubMed ID: 26972515 [TBL] [Abstract][Full Text] [Related]
15. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. Dandona L; Sisodia P; Kumar SG; Ramesh YK; Kumar AA; Rao MC; Marseille E; Someshwar M; Marshall N; Kahn JG BMC Public Health; 2005 Sep; 5():98. PubMed ID: 16181491 [TBL] [Abstract][Full Text] [Related]
16. HIV prevention programme cascades: insights from HIV programme monitoring for female sex workers in Kenya. Bhattacharjee P; Musyoki HK; Becker M; Musimbi J; Kaosa S; Kioko J; Mishra S; Isac SK; Moses S; Blanchard JF J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25311. PubMed ID: 31328436 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence of HIV among female sex workers and their clients: modelling the potential effects of intervention in Rwanda. Nsanzimana S; Mills EJ; Harari O; Mugwaneza P; Karita E; Uwizihiwe JP; Park JJ; Dron L; Condo J; Bucher H; Thorlund K BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32764126 [TBL] [Abstract][Full Text] [Related]
18. Positive impact of increases in condom use among female sex workers and clients in a medium HIV prevalence epidemic: modelling results from Project SIDA1/2/3 in Cotonou, Benin. Williams JR; Alary M; Lowndes CM; Béhanzin L; Labbé AC; Anagonou S; Ndour M; Minani I; Ahoussinou C; Zannou DM; Boily MC PLoS One; 2014; 9(7):e102643. PubMed ID: 25047804 [TBL] [Abstract][Full Text] [Related]
19. A risk-differentiated, community-led intervention to strengthen uptake and engagement with HIV prevention and care cascades among female sex workers in Zimbabwe (AMETHIST): a cluster randomised trial. Cowan FM; Machingura F; Ali MS; Chabata ST; Takaruza A; Dirawo J; Makamba M; Hove T; Bansi-Matharu L; Matambanadzo P; Shahmanesh M; Busza J; Steen R; Yekeye R; Mpofu A; Mugurungi O; Phillips AN; Hargreaves JR Lancet Glob Health; 2024 Sep; 12(9):e1424-e1435. PubMed ID: 39151978 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention. Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]